Novel aromatic compounds and their use in medical applications

作者: Remo Dr. Kranich , Ewald M Dr. Aydt , Anke S. Dr. Busemann

DOI:

关键词:

摘要: Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) and a pharmaceutically acceptable carrier wherein symbols have following meaning -X- is e.g. Y being salts can be applied to modulate in-vitro in-vivo binding processes mediated by E-, P- L-selectin binding.

参考文章(74)
R. P. McEver, Interactions of selectins with PSGL-1 and other ligands. Ernst Schering Research Foundation workshop. pp. 137- 147 ,(2004) , 10.1007/978-3-662-05397-3_8
Yoshimichi Yoshimura, Shin Watanabe, Masayoshi Kikuchi, Method for determining coagulation parameters ,(1998)
Harry Brielmann, Rajagopal Bakthavatchalam, James Darrow, Stephane DeLombaert, Xiaozhang Zheng, Charles Blum, Taeyoung Yoon, Substituted biphenyl-4-carboxylic acid arylamide analogues ,(2003)
Marcel Robert Kling, Christopher John Burns, Nicotinamide-based kinase inhibitors ,(2003)
Michael P Schön, Inhibitors of selectin functions in the treatment of inflammatory skin disorders Therapeutics and Clinical Risk Management. ,vol. 1, pp. 201- 208 ,(2005)
Julius Axelrod, Robert Tomchick, Enzymatic O-Methylation of Epinephrine and Other Catechols Journal of Biological Chemistry. ,vol. 233, pp. 702- 705 ,(1958) , 10.1016/S0021-9258(18)64731-3